Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE Cause Product prescribing issue? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Product prescribing issue have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.0% of all adverse event reports for PANTOPRAZOLE.

26
Reports of Product prescribing issue with PANTOPRAZOLE
0.0%
of all PANTOPRAZOLE reports
0
Deaths
19
Hospitalizations

How Dangerous Is Product prescribing issue From PANTOPRAZOLE?

Of the 26 reports, 19 (73.1%) required hospitalization, and 11 (42.3%) were considered life-threatening.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE Cause?

Chronic kidney disease (28,127) Acute kidney injury (15,961) Renal failure (11,543) End stage renal disease (8,523) Renal injury (7,070) Drug ineffective (5,487) Off label use (4,279) Pain (4,057) Dyspnoea (4,052) Fatigue (3,797)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which PANTOPRAZOLE Alternatives Have Lower Product prescribing issue Risk?

PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS PANTOPRAZOLE vs PANTOTHENIC ACID PANTOPRAZOLE vs PAPAVERINE PANTOPRAZOLE vs PARACETAMOL PANTOPRAZOLE vs PARATHYROID HORMONE

Related Pages

PANTOPRAZOLE Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue PANTOPRAZOLE Demographics